Out-of-pocket costs are on the rise for commonly prescribed neurologic medications
Citation Manager Formats
Make Comment
See Comments

In the article “Out-of-pocket costs are on the rise for commonly prescribed neurologic medications" by Callaghan et al.,1 first published online May 1, 2019, the 2004 out-of-pocket costs for MS medications (mean [SD]) in the Abstract and Results should be $33 ($50) rather than $15 ($23), and the 2004 median/IQR in the Results should be $25 ($20--$32) rather than $14 ($10--$16). The authors regret the errors.
- © 2019 American Academy of Neurology
Reference
- 1.↵
- Callaghan BC,
- Reynolds E,
- Banerjee M, et al.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Alert Me
Recommended articles
-
Article
Out-of-pocket costs are on the rise for commonly prescribed neurologic medicationsBrian C. Callaghan, Evan Reynolds, Mousumi Banerjee et al.Neurology, May 01, 2019 -
Research
Closing the Part D Coverage Gap and Out-of-Pocket Costs for Multiple Sclerosis DrugsDaniel M. Hartung, Kirbee A. Johnston, Dennis N. Bourdette et al.Neurology: Clinical Practice, August 28, 2020 -
Article
Association of out-of-pocket costs on adherence to common neurologic medicationsEvan L. Reynolds, James F. Burke, Mousumi Banerjee et al.Neurology, February 19, 2020 -
Patient Page
Rising medication costs for patients with neurologic disordersLyell K. Jones, Jr et al.Neurology, May 27, 2019